Interrad Medical

Interrad Medical is a commercial-stage medical device company focused on catheter securement. Its flagship product, SecurAcath®, is a subcutaneous anchor that physically fixes the catheter at the insertion site, aiming to reduce complications like dislodgement, migration, and central line-associated bloodstream infections (CLABSIs). The company has built a strong clinical evidence base, including a recent positive randomized controlled trial (SECURED), and has secured key contracts, such as an Innovative Technology Contract from Vizient, indicating adoption by major healthcare providers. Interrad operates in the large and growing market for vascular access devices, competing against traditional adhesive securement methods.

Subcutaneous Anchor Securement System (SASS) using a nitinol anchor deployed beneath the skin to mechanically fixate catheters (PICCs, CVCs, drains), eliminating reliance on adhesive securement.

Interrad Medical primarily competes against the entrenched standard of care: adhesive securement devices (e.g., 3M's Tegaderm IV Securement), sutures, and tape. It also faces competition from other alternative securement devices, such as sutureless securement devices (e.g., Bard's StatLock). Its key differentiator is the subcutaneous mechanical anchor, which aims to offer superior stability and potentially lower infection risk compared to surface-level adhesive solutions.